Summary of opinion: Tecentriq,atezolizumab, 17/09/2020, Positive
Summary of opinion: Tecentriq,atezolizumab, 17/09/2020, Positive
Italiano
Summary of opinion: Tecentriq,atezolizumab, 17/09/2020, Positive
Summary of opinion: Elzonris,tagraxofusp, 23/07/2020, Negative
Summary of opinion: Supemtek,quadrivalent influenza vaccine (recombinant, prepared in cell culture), 17/09/2020, Positive
Summary of opinion: Velphoro,mixture of polynuclear iron(III)-oxyhydroxide, sucrose and starches, 17/09/2020, Positive
Summary of opinion: Kalydeco,ivacaftor, 17/09/2020, Positive
Summary of opinion: Olumiant,baricitinib, 17/09/2020, Positive
Summary of opinion: Fycompa,perampanel, 17/09/2020, Positive
Summary of opinion: Opdivo,nivolumab, 17/09/2020, Positive
Summary of opinion: Exparel,bupivacaine, 17/09/2020, Positive
Summary of opinion: MenQuadfi,meningococcal group A, C, W and Y conjugate vaccine, 17/09/2020, Positive
80.211.154.110